Duration of operation and diagnosis of hepatitis B (HBV) is an independent risk factor for surgical site infections after liver transplantation
Department of General Surgery, Bursa Uludağ University Faculty of Medicine, Bursa, Türkiye
Objective: Surgical site infections (SSI) are the most common complications after liver transplantation (LT). Although there are some risk factors known in the literature after LT, the available data is insufficient for routine use. In the present study, it was aimed to define the parameters that may be used to clearly determine the risk of SSI after LT in our clinic.
Material and Methods: In the present study, we evaluated 329 patients who underwent liver transplantation with regard to risk factors for surgical site infections. The relation between demographic data and SSI was evaluated using SPSS, Graphpad, and Medcalc statistical programs.
Results: In a total of 329 patients, SSIs were determined in 37 (11.24%). Among the 37 patients, 24 were classified as organ space (64.9%) and 13 as deep SSI (35.1%). None of these patients developed superficial incisional infection. SSI showed statistically significant relation with operation time (p= 0.008), diabetes (p= 0.004), and cirrhosis due to hepatitis B (p< 0.001).
Conclusion: As a result, deep and organ space infections are much more observed in patients undergoing liver transplantation with hepatitis B, diabetes mellitus and prolonged surgery. This is thought to have developed because of chronic irritation and increased inflammation. Since data on hepatitis B and duration of surgery are limited in the literature, this study is considered to be a contribution to the literature.
Keywords: Surgical site infection, liver transplantation, operation time
Cite this article as: Aksoy F, Dündar HZ, Kaya E. Duration of operation and diagnosis of hepatitis B (HBV) is an independent risk factor for surgical site infections after liver transplantation. Turk J Surg 2022; 38 (3): 289-293.
The approval for this study was obtained from Uludağ University Faculty of Medicine Clinical Research Ethics Committee (Decision no: 2020-12/17, Date: 08.07.2020).
Concept - E.K.; Design - F.A.; Supervision - H.Z.D.; Fundings - F.A.; Materials - F.A.; Data Collection and/or Processing - E.K.; Analysis and/or Interpretation - H.Z.D.; Literature Search - F.A.; Writing Manuscript - H.Z.D., F.A.; Critival Review - E.K.
The authors have no conflicts of interest to declare.
The authors declared that this study has received no financial support.